Guardant Health (NASDAQ: GH) net income
Guardant Health reported a net loss of $416.3m for fiscal 2025; in fiscal 2024 it reported a net loss of $436.4m. Earnings per share were −$3.32.
Guardant Health's best year of the last 9 was fiscal 2019. It reported a loss in 9 of those 9 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$416.3m | — | −42.4% | −$3.32 |
| 2024 | −$436.4m | — | −59.0% | −$3.56 |
| 2023 | −$479.4m | — | −85.0% | −$4.28 |
| 2022 | −$654.6m | — | −145.6% | −$6.41 |
| 2021 | −$384.8m | — | −103.0% | −$4.00 |
| 2020 | −$246.3m | — | −85.9% | −$2.60 |
| 2019 | −$75.7m | — | −35.3% | −$0.84 |
| 2018 | −$85.1m | — | −93.8% | — |
| 2017 | −$83.2m | — | −167.0% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Guardant Health net income compared with its sector
By net income for its latest fiscal year, Guardant Health ranks 469th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Guardant Health, −42.4%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 467th | Intellia Therapeutics | −$412.7m | −609.9% |
| 468th | Agios Pharmaceuticals | −$412.8m | −764.0% |
| 469th | Guardant Health | −$416.3m | −42.4% |
| 470th | Vir Biotechnology | −$438.0m | −638.9% |
| 471st | Oscar Health | −$443.2m | −3.8% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Guardant Health
- How much did Guardant Health earn in fiscal 2025?
- Guardant Health reported a net loss of $416.3m for fiscal 2025. In fiscal 2024 it reported a net loss of $436.4m.
- What are the earnings per share of Guardant Health?
- They were −$3.32 in fiscal 2025, compared with −$3.56 in fiscal 2024.
- Where does Guardant Health rank in its sector by net income?
- It ranks 469th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Guardant Health come from?
- From the annual report (Form 10-K) that Guardant Health files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Guardant Health files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Guardant Health: the Guardant Health page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.